Company Albireo Pharma, Inc. Deutsche Boerse AG
Equities
BDQM
US01345P1066
Biotechnology & Medical Research
Business Summary
Number of employees: 130
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 61 | 31/05/15 |
Founder | 60 | 07/12/03 | |
President | 57 | 01/03/23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 12/04/21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 18/12/22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 01/03/23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 03/11/19 |
Muffy Carter
LAW | General Counsel | 71 | 28/11/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 01/03/23 | |
Director/Board Member | 62 | 01/03/23 | |
Ronald Cooper
CEO | Chief Executive Officer | 61 | 31/05/15 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,709,043 | 18,650,831 ( 90.06 %) | 7,760 ( 0.0375 %) | 90.06 % |
Company contact information
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Sector
1st Jan change | Capi. | |
---|---|---|
+19.08% | 125B | |
+14.42% | 108B | |
-4.84% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.32% | 16.5B | |
+2.65% | 13.39B | |
+29.10% | 11.1B |